Related Experiment Video

Updated: Jul 17, 2026

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

Necrotic tumor cell death in vivo impairs tumor-specific immune responses

Jaba Gamrekelashvili1, Christine Krüger, Reinhard von Wasielewski

  • 1Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.

Journal of Immunology (Baltimore, Md. : 1950)
|January 24, 2007
PubMed

Insights

Cell death by necrosis impairs anti-tumor immune responses, unlike apoptosis. Necrotic tumor cell death reduces CD8(+) T cell function, hindering tumor protection, while apoptotic cell death promotes it. Anti-CD40 therapy can restore immune function.

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • The mode of cell death influences immune responses to released antigens.
  • Understanding in vivo immune reactions to tumor cell death is crucial for immunotherapy.

Purpose of the Study:

  • To directly analyze tumor-specific immune responses to in vivo apoptosis versus necrosis.
  • To investigate the impact of different cell death modalities on anti-tumor immunity.

Main Methods:

  • Mice with thymidine kinase-transfected tumors were treated to induce apoptosis (ganciclovir) or necrosis (ZD6126).
  • Analysis of tumor-specific CD8(+) T cell frequency and function.
  • Adoptive transfer of lymphocytes and assessment of tumor protection.
  • Evaluation of anti-CD40 treatment efficacy.

Main Results:

  • Tumor cell necrosis, unlike apoptosis, reduced the frequency and impaired the function of tumor-specific CD8(+) T cells.
  • Adoptive transfer of lymphocytes from apoptotic tumor models conferred significant tumor protection, absent in necrotic models.
  • Anti-CD40 treatment reversed the impaired CD8(+) T cell responses in mice with necrotic tumors.

Conclusions:

  • The mechanism of tumor cell death significantly dictates the ensuing anti-tumor immune response.
  • Apoptotic cell death promotes protective anti-tumor immunity, whereas necrotic cell death is immunosuppressive.
  • Targeting necrotic cell death pathways or using immune-modulating agents like anti-CD40 may enhance immunotherapy efficacy.

More Related Videos

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Cellular Injury IV: Necrosis01:16

Cellular Injury IV: Necrosis

Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...